Device Trial Radar · NCT04249492
PMCF Study on EDOF (Isopure) vs Monofocal (Micropure) IOL
Last checked: Nov 20, 2026Latest source record: Nov 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
250
Actual
Start
Feb 11, 2020
Primary completion
Feb 23, 2023
Study completion Apr 18, 2024
Sponsor
- Lead sponsor
- Beaver-Visitec International, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- targomedGmbH
- First posted
- Jan 31, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Multicenter, prospective, randomised, controlled, single-blind post-market clinical follow-up (PMCF) study to compare the clinical outcomes of an enhanced depth of focus (EDOF) IOL with the outcomes obtained with a monofocal lens. Implantation of the IOLs is bilaterally.
Conditions
- Cataract
- Lens Opacities
Interventions
IOL implantation experimental (Isopure 1.2.3.)Device
Implantation of trifocal IOL POD F GF consisting of light distribution order: far \> intermediate \> near
IOL implantation active comparator (Micropure 1.2.3.)Device
Implantation of trifocal IOL POD F GF consisting of light distribution order: far \> near \> intermediate
Primary outcomes
What the sponsor says the trial is designed to measure.
- monocular Best Corrected Distance Visual Acuity (CDVA) under photopic light conditions on the first implanted eye.Time frame: 6 months (120-180 days) postoperative
Locations
12 sites in 6 countries. Site status is shown where the registry gives one.
Hanusch Krankenhaus
Vienna, Austria
Gemini Eye Clinic
Zlín, Czechia
Augen-Zentrum-Nordwest
Ahaus, Germany
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.